在肺大细胞神经内分泌癌中基于转录因子的亚型分配
Yin P Hung1, Komson Wannasai1,2, Catherine B Meador3
1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Histopathology
|November 26, 2025
概括
基于转录因子的亚型化有助于区分肺大细胞神经内分泌癌 (LCNEC) 和小细胞肺癌 (SCLC). 在LCNEC中,YAP1和HNF4A的表达与大细胞形态相关.
科学领域:
- 肺病理学和瘤学
- 在癌症中的分子诊断.
- 神经内分泌瘤亚型化
背景情况:
- 肺大细胞神经内分泌癌 (LCNEC) 诊断是具有挑战性的,因为它与小细胞肺癌 (SCLC) 重叠.
- 小细胞肺癌 (SCLC) 呈现出各种基于转录因子的亚型.
- 了解LCNEC异质性对于准确的诊断和治疗至关重要.
研究的目的:
- 调查基于转录因子的肺LCNEC亚型的临床病理学意义.
- 评估特定转录因子表达和LCNEC形态之间的相关性.
- 通过分子亚型化来区分LCNEC和SCLC.
主要方法:
- 对117名被诊断患有肺LCNEC或高度神经内分泌癌 (组合/中间形态) 的患者样本的分析.
- 对转录因子ASCL1,NeuroD1,POU2F3,YAP1和HNF4A的免疫组织化学 (IHC) 使用H分数进行亚型化.
- 在选定的病例中进行了下一代测序 (NGS).
- IHC亚型结果与细胞形态特征和临床数据的相关性.
主要成果:
- IHC亚型确定了ASCL1 (62%),YAP1 (17%),NeuroD1 (8%),POU2F3 (6%) 和HNF4A (2%) 的主导表达.
- 在LCNEC中,YAP1和HNF4A的表达与大细胞形态显著相关.
- POU2F3表达与ASCL1,NeuroD1和HNF4A相互排斥,并在一些具有驱动突变的中间瘤中发现.
- 在结合/中间形态的瘤中,NeuroD1的主导性更频繁.
结论:
- 基于转录因子的亚型,特别是YAP1和HNF4A的表达,是识别肺神经内分泌瘤中大细胞形态的一个有价值的工具.
- 这种亚型化方法有助于区分LCNEC和SCLC,并了解瘤异质性.
- 分子亚型化可能为LCNEC内部的不同生物行为和潜在的治疗点提供洞察力.
相关概念视频
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
General Transcription Factors
6.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.7K
Transcription Factors
82.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.2K
Master Transcription Regulators
7.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
Non-LTR Retrotransposons
13.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K
Transducer Mechanism: Nuclear Receptors
2.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.3K


